189 related articles for article (PubMed ID: 11287236)
1. Therapeutic antibody expression technology.
Chadd HE; Chamow SM
Curr Opin Biotechnol; 2001 Apr; 12(2):188-94. PubMed ID: 11287236
[TBL] [Abstract][Full Text] [Related]
2. Of mice and men: hybridoma and recombinant antibodies.
Little M; Kipriyanov SM; Le Gall F; Moldenhauer G
Immunol Today; 2000 Aug; 21(8):364-70. PubMed ID: 10916138
[TBL] [Abstract][Full Text] [Related]
3. Manufacturing of recombinant therapeutic proteins in microbial systems.
Graumann K; Premstaller A
Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
[TBL] [Abstract][Full Text] [Related]
4. Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics.
Kellermann SA; Green LL
Curr Opin Biotechnol; 2002 Dec; 13(6):593-7. PubMed ID: 12482519
[TBL] [Abstract][Full Text] [Related]
5. Established bioprocesses for producing antibodies as a basis for future planning.
Farid SS
Adv Biochem Eng Biotechnol; 2006; 101():1-42. PubMed ID: 16989256
[TBL] [Abstract][Full Text] [Related]
6. Formatting antibody fragments to mediate specific therapeutic functions.
Weir AN; Nesbitt A; Chapman AP; Popplewell AG; Antoniw P; Lawson AD
Biochem Soc Trans; 2002 Aug; 30(4):512-6. PubMed ID: 12196125
[TBL] [Abstract][Full Text] [Related]
7. Production technologies for monoclonal antibodies and their fragments.
Andersen DC; Reilly DE
Curr Opin Biotechnol; 2004 Oct; 15(5):456-62. PubMed ID: 15464378
[TBL] [Abstract][Full Text] [Related]
8. Affinity of recombinant antibody and antibody fragment binding to human thyroglobulin: potential applications in gene therapy.
Mani JC; Noel D; Marin M; Navarro-Teulon I; Biard-Piechaczyk M; Pau B; Piechaczyk M
J Mol Recognit; 1998; 11(1-6):117-8. PubMed ID: 10076821
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms.
Frenken LG; Hessing JG; Van den Hondel CA; Verrips CT
Res Immunol; 1998; 149(6):589-99. PubMed ID: 9835423
[No Abstract] [Full Text] [Related]
10. Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications.
Yazaki PJ; Shively L; Clark C; Cheung CW; Le W; Szpikowska B; Shively JE; Raubitschek AA; Wu AM
J Immunol Methods; 2001 Jul; 253(1-2):195-208. PubMed ID: 11384681
[TBL] [Abstract][Full Text] [Related]
11. Production of antibody fragments in a bioreactor.
Hellebust H
Methods Mol Biol; 2003; 207():437-41. PubMed ID: 12412490
[No Abstract] [Full Text] [Related]
12. Production of antibodies and antibody fragments in plants.
Peeters K; De Wilde C; De Jaeger G; Angenon G; Depicker A
Vaccine; 2001 Mar; 19(17-19):2756-61. PubMed ID: 11257420
[TBL] [Abstract][Full Text] [Related]
13. Optimal nitrogen supply as a key to increased and sustained production of a monoclonal full-size antibody in BY-2 suspension culture.
Holland T; Sack M; Rademacher T; Schmale K; Altmann F; Stadlmann J; Fischer R; Hellwig S
Biotechnol Bioeng; 2010 Oct; 107(2):278-89. PubMed ID: 20506104
[TBL] [Abstract][Full Text] [Related]
14. High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate.
Grünberg J; Knogler K; Waibel R; Novak-Hofer I
Biotechniques; 2003 May; 34(5):968-72. PubMed ID: 12765023
[TBL] [Abstract][Full Text] [Related]
15. Specific production rate of VHH antibody fragments by Saccharomyces cerevisiae is correlated with growth rate, independent of nutrient limitation.
Thomassen YE; Verkleij AJ; Boonstra J; Verrips CT
J Biotechnol; 2005 Aug; 118(3):270-7. PubMed ID: 15979755
[TBL] [Abstract][Full Text] [Related]
16. Trends in Monoclonal Antibody Production Using Various Bioreactor Syst.
Jyothilekshmi I; Jayaprakash NS
J Microbiol Biotechnol; 2021 Mar; 31(3):349-357. PubMed ID: 32238761
[TBL] [Abstract][Full Text] [Related]
17. Production of antibodies in transgenic plants.
Larrick JW; Yu L; Chen J; Jaiswal S; Wycoff K
Res Immunol; 1998; 149(6):603-8. PubMed ID: 9835425
[TBL] [Abstract][Full Text] [Related]
18. Biochemical engineering.
Carrondo MJ; Aunins JG
Curr Opin Biotechnol; 2004 Oct; 15(5):441-3. PubMed ID: 15464375
[No Abstract] [Full Text] [Related]
19. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
20. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
Weisser NE; Hall JC
Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
